<DOC>
	<DOCNO>NCT00515684</DOCNO>
	<brief_summary>The purpose study determine whether topical bevacizumab safe use corneal neovascularization long term period .</brief_summary>
	<brief_title>Corneal Thinning During Topical Bevacizumab Therapy</brief_title>
	<detailed_description />
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Corneal Neovascularization</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>clinical diagnosis corneal neovascularization must able apply eyedrop active keratitis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>